The JAK2 inhibitor TG101209 exhibits anti-tumor and chemotherapeutic sensitizing effects on Burkitt lymphoma cells by inhibiting the JAK2/STAT3/c-MYB signaling axis

by Yang Zhang, Ji Li, Haiying Zhong, Xiang Xiao, Zhihua Wang, Zhao Cheng, Cunhong Hu, Guangsen Zhang, Sufang Liu
Published 2021-09-01